Endpoint News editor, Jared Whitlock, featured our CEO, Alok Tayi, in an article on how parents of children with rare disease are challenging the status quo in drug development.
“The challenge for rare diseases isn’t necessarily finding a treatment — it’s funding it,” said Alok Tayi, CEO and co-founder of Vibe Biotechnology”
